The utility of whole-body diffusion-weighted MRI for delineating regions of interest in PET

被引：3
|
作者：
Blackledge, M. D. [1 ,2 ,3 ]
Koh, D. M. [4 ]
Collins, D. J. [1 ,2 ,3 ]
Chua, S. [5 ]
Leach, M. O. [1 ,2 ,3 ]
机构：
[1] CR UK, Surrey, England
[2] Inst Canc Res, EPSRC Canc Imaging Ctr, Surrey, England
[3] Royal Marsden Hosp, Surrey, England
[4] Royal Marsden Hosp NHS Fdn Trust, Dept Radiol, Surrey, England
[5] Royal Marsden Hosp NHS Fdn Trust, Dept Nucl Med & PET, Surrey, England
来源：
NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT | 2013年 / 702卷
基金：
美国国家卫生研究院; 英国工程与自然科学研究理事会;
关键词：
Diffusion-weighted MRI; PET/CT; PET/MRI; Cancer biomarkers; Lymphoma; SUV; UPTAKE VALUES; ONCOLOGY;
D O I：
10.1016/j.nima.2012.08.083
中图分类号：
TH7 [仪器、仪表];
学科分类号：
0804 ; 080401 ; 081102 ;
摘要：
In this technological report, we investigate the utility of whole-body diffusion-weighted MRI (WBDWI) as a prior for defining regions of interest (ROI) in PET data. Due to its comparatively high resolution and excellent lesion-to-background ratio, semi-automatic segmentation is possible in WBDWI. Following rigid registration of PET to WBDWI, a simple, fast and automatic algorithm can be used to define ROIs in PET data. This approach is applied to a test cohort of patients diagnosed with lymphoma who underwent both (18)FDG-PET/CT and WBDWI studies to demonstrate its potential application. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码：148 / 151
页数：4
相关论文
共 50 条
  • [41] Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients
    Abdulqadhr, Goran
    Molin, Daniel
    Astrom, Gunnar
    Suurkula, Madis
    Johansson, Lars
    Hagberg, Hans
    Ahlstrom, Hakan
    ACTA RADIOLOGICA, 2011, 52 (02) : 173 - 180
  • [42] Role of whole-body diffusion-weighted imaging in evaluation of multiple myeloma
    Wang, Jiping
    Zhang, Bei
    Zhang, Rongkui
    Zhang, Li
    Jiang, Wenyan
    Jiang, Yaqiu
    MEDICINE, 2021, 100 (35)
  • [43] Staging of Primary Abdominal Lymphomas: Comparison of Whole-Body MRI with Diffusion-Weighted Imaging and 18F-FDG-PET/CT
    Stecco, Alessandro
    Buemi, Francesco
    Quagliozzi, Martina
    Lombardi, Mariangela
    Santagostino, Alberto
    Sacchetti, GianMauro
    Carriero, Alessandro
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2015, 2015
  • [44] ASSESSING MYELOMA BONE DISEASE WITH WHOLE-BODY DIFFUSION-WEIGHTED MRI: COMPARISON WITH FDG PET-CT AND ASSESSMENT OF ADC VALUE
    Narita, K.
    Usui, Y.
    Suehara, Y.
    Fujisawa, M.
    Fukumoto, K.
    Takeuchi, M.
    Ouchi, E.
    Kikuchi, Y.
    Ouchi, T.
    Matsue, K.
    HAEMATOLOGICA, 2016, 101 : 537 - 537
  • [45] Whole-body MRI and diffusion MRI
    Anwar R Padhani
    Cancer Imaging, 14 (Suppl 1)
  • [46] Whole-body diffusion-weighted MRI and 18F-FDG PET/CT can discriminate between different lymphoma subtypes
    Mosavi, F.
    Wassberg, C.
    Selling, J.
    Molin, D.
    Ahlstrom, H.
    CLINICAL RADIOLOGY, 2015, 70 (11) : 1229 - 1236
  • [47] Characterization of Residual Lymphoma Masses After 2 Cycles of Chemotherapy Using Whole-Body Diffusion-Weighted MRI and FDG-PET
    Lin, C.
    Mule, S.
    Piekarski, E.
    Blanc-Durand, P.
    Zerbib, P.
    Ricci, R.
    Belhadj, K.
    Yen, T.
    Haioun, C.
    Rahmouni, A.
    Luciani, A.
    Itti, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S487 - S487
  • [48] Whole-body diffusion-weighted imaging for staging malignant lymphoma in children
    Kwee, Thomas C.
    Takahara, Taro
    Vermoolen, Malou A.
    Bierings, Marc B.
    Mali, Willem P.
    Nievelstein, Rutger A. J.
    PEDIATRIC RADIOLOGY, 2010, 40 (10) : 1592 - 1602
  • [49] Whole-body diffusion-weighted imaging for staging malignant lymphoma in children
    Thomas C. Kwee
    Taro Takahara
    Malou A. Vermoolen
    Marc B. Bierings
    Willem P. Mali
    Rutger A. J. Nievelstein
    Pediatric Radiology, 2010, 40 : 1592 - 1602
  • [50] 11C-choline PET/CT and whole-body MRI including diffusion-weighted imaging for patients with recurrent prostate cancer
    Wieder, Hinrich
    Beer, Ambros J.
    Holzapfel, Konstantin
    Henninger, Martin
    Maurer, Tobias
    Schwarzenboeck, Sarah
    Rummeny, Ernst J.
    Eiber, Matthias
    Stollfuss, Jens
    ONCOTARGET, 2017, 8 (39) : 66516 - 66527
12345